Overview
Reactions Weekly is your trusted source for timely and clinically relevant updates on adverse drug reaction (ADR) news and published adverse drug event reports.
Reactions Weekly provides a weekly round-up of adverse drug reaction news including labelling changes, drug withdrawals due to safety issues, adverse reaction research and current issues in drug safety. Content is sourced from journals, scientific meetings, media releases, regulatory agency websites, and bulletins from the national regulatory agencies. The focus remains on the most impactful ADR information for healthcare practitioners, researchers, and policy makers.
The case summaries in Reactions Weekly are sourced from AdisInsight. They include reports that meet the criteria for AdisInsight Safety categories 1 and 2. For more information, please visit AdisInsight.
Contact: For more information or enquiries, please contact Nitin Joshi at nitin.joshi@springer.com
- Editor
-
- Nitin Joshi
Journal metrics
- Downloads
- 1.4M (2025)
Latest issue
Latest articles
-
Summary 28 March 2026 Pages: 200 - 200
-
Warfarin
Summary 28 March 2026 Pages: 199 - 199 -
Vedolizumab
Summary 28 March 2026 Pages: 198 - 198 -
Vancomycin
Summary 28 March 2026 Pages: 197 - 197 -
Vancomycin
Summary 28 March 2026 Pages: 196 - 196
Journal information
- Electronic ISSN
- 1179-2051
- Abstracted and indexed in
-
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Dimensions
- EBSCO
- Japanese Science and Technology Agency (JST)
- Naver
- OCLC WorldCat Discovery Service
- Ovid Discovery
- Portico
- ProQuest
- Semantic Scholar
- TD Net Discovery Service
- Wanfang
- eLibrary.ru
- © Springer Nature Switzerland AG
